

Biotechnology firm Silence Therapeutics announced a five million pound placing to Henderson Global Investors and Ora Capital. New shares were placed...


Alistair Darby, the Chief Executive Officer of Mitchells & Butlers, the UK's largest operator of managed restaurants and pub, has boosted his holding ...


Shares in biotechnology firm Silence Therapeutics took a hit on Monday despite the company revealing that the US Patent and Trademark Office (USPTO) h...


Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost...


Biotechnology firm Silence Therapeutics is to tap the market, offering shares at a sharp discount, as it seeks to bolster its balance sheet. The grou...


The biotech firm Silence Therapeutics has announced a partnership with what it describes as "one of the world's leading pharmaceutical companies". Th...


Partnerships with big drug companies such as AstraZeneca lifted revenues at drug discovery group Silence Therapeutics in 2010, though losses also grew...


Silence Therapeutics recovered sharply from a 52-week low after it announced a favourable set of results from a phase II trial of a drug developed by ...